日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Experience of Women With Breast or Gynecological Cancer After Participation in an Online Mindfulness-Based Cancer Recovery (e-MBCR) Program: Secondary Outcomes Analysis of a Pilot Mixed Methods Randomized Controlled Trial

参与在线正念癌症康复（e-MBCR）项目后乳腺癌或妇科癌症女性的体验：一项混合方法随机对照试验的次要结果分析

期刊:Psycho-Oncology
影响因子:3.5
doi:10.1002/pon.70334
Gaignard, Marie-Estelle; Martin, Dominica; Stanic, Jelena; Hilfiker, Roger; Bodmer, Alexandre; Ljuslin, Michael; Zaman, Khalil; Labidi-Galy, Intidhar; Sarivalasis, Apostolos; Carlson, Linda E; Peters, Solange; Dietrich, Pierre-Yves; Eicher, Manuela; Bondolfi, Guido; Jermann, Françoise
BCR
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Intersecting Anemias: PARP Inhibitor-Induced Toxicity and Autoimmune Hemolysis-A Case Report

交叉性贫血：PARP抑制剂诱导的毒性和自身免疫性溶血——病例报告

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.70112
Dereme, Julien; Asonitis, Konstantinos; Grandoni, Francesco; Liapi, Aikaterini; Sarivalasis, Apostolos; Tsilimidos, Gerasimos
代谢
PARP
毒理研究
贫血
免疫/内分泌
发表日期：2025
文献求助 收藏

Are Poly (ADP-Ribose) Polymerase Inhibitors Safe in Paraneoplastic Dermatomyositis due to High-Grade Serous Carcinoma of the Ovary? A Case Report and a Review of the Literature

聚（ADP-核糖）聚合酶抑制剂在卵巢高级别浆液性癌引起的副肿瘤性皮肌炎中是否安全？病例报告及文献综述

期刊:Case Reports in Oncology
影响因子:0.7
doi:10.1159/000546665
Koheeallee, Kaneez; Sarivalasis, Apostolos
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial

一项由药剂师主导的跨专业药物依从性计划提高了口服抗癌疗法的依从性：OpTAT随机对照试验

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0304573
Bandiera, Carole; Cardoso, Evelina; Locatelli, Isabella; Zaman, Khalil; Diciolla, Antonella; Digklia, Antonia; Stravodimou, Athina; Cristina, Valérie; Aedo-Lopez, Veronica; Dolcan, Ana; Sarivalasis, Apostolos; Bouchaab, Hasna; Pasquier, Jérôme; Dotta-Celio, Jennifer; Peters, Solange; Wagner, Dorothea; Csajka, Chantal; Schneider, Marie Paule
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy

卵巢癌患者DC亚群的纵向分析：对免疫疗法的启示

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1119371
Mastelic-Gavillet, Beatris; Sarivalasis, Apostolos; Lozano, Leyder Elena; Lofek, Sebastien; Wyss, Tania; Melero, Ignacio; de Vries, I Jolanda M; Harari, Alexandre; Romero, Pedro; Kandalaft, Lana Elias; Viganó, Selena
肿瘤
免疫/内分泌
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature

复发性浆液性交界性卵巢肿瘤的淋巴结受累情况：现有证据、争议及文献综述

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15030890
Wetterwald, Laureline; Sarivalasis, Apostolos; Liapi, Aikaterini; Mathevet, Patrice; Achtari, Chahin
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study

OpTAT 研究中，药代动力学模型支持患者坚持服用 CDK 4/6 抑制剂帕博西尼，并省略剂量管理。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15010316
Bandiera, Carole; Locatelli, Isabella; Courlet, Perrine; Cardoso, Evelina; Zaman, Khalil; Stravodimou, Athina; Dolcan, Ana; Sarivalasis, Apostolos; Zurcher, Jean-Philippe; Aedo-Lopez, Veronica; Dotta-Celio, Jennifer; Peters, Solange; Guidi, Monia; Wagner, Anna Dorothea; Csajka, Chantal; Schneider, Marie P
发表日期：2023
文献求助 收藏

Dual first-line maintenance by PARP inhibitor and bevacizumab can cause confusion in high-grade serous ovarian cancer: A case of PRES and a review of the literature

PARP抑制剂联合贝伐单抗一线维持治疗在高级别浆液性卵巢癌中可能引起混淆：一例PRES病例报告及文献综述

期刊:SAGE Open Medical Case Reports
影响因子:0.6
doi:10.1177/2050313X231176401
Liapi, Aikaterini; Atat, Chirine; Dunet, Vincent; Sarivalasis, Apostolos
PARP
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

低剂量放射疗法可逆转肿瘤免疫沙漠化和免疫治疗耐药性

期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-21-0003
Fernanda G Herrera ，Catherine Ronet ，Maria Ochoa de Olza # ，David Barras # ，Isaac Crespo # ，Massimo Andreatta ，Jesus Corria-Osorio ，Aodrenn Spill ，Fabrizio Benedetti ，Raphael Genolet ，Angela Orcurto ，Martina Imbimbo ，Eleonora Ghisoni ，Blanca Navarro Rodrigo ，Dominik R Berthold ，Apostolos Sarivalasis ，Khalil Zaman ，Rafael Duran ，Clarisse Dromain ，John Prior ，Niklaus Schaefer ，Jean Bourhis ，Georgia Dimopoulou ，Zoi Tsourti ，Marius Messemaker ，Thomas Smith ，Sarah E Warren ，Periklis Foukas ，Sylvie Rusakiewicz ，Mikaël J Pittet ，Stefan Zimmermann ，Christine Sempoux ，Urania Dafni ，Alexandre Harari ，Lana E Kandalaft ，Santiago J Carmona ，Denarda Dangaj Laniti ，Melita Irving # ，George Coukos #
治疗耐药
免疫/内分泌
肿瘤免疫
肿瘤
发表日期：2022
文献求助 收藏

Pneumomediastinum as a Complication of Oral and Maxillofacial Injuries: Report of 3 Cases and a 50-Year Systematic Review of Case Reports

纵隔气肿作为口腔颌面部损伤的并发症：3例病例报告及50年病例报告系统回顾

期刊:Craniomaxillofacial Trauma & Reconstruction
影响因子:0.4
doi:10.1177/1943387521997236
Papadiochos, Ioannis Yiannis; Sarivalasis, Stavros-Evangelos; Chen, Meg; Goutzanis, Lampros; Kalyvas, Aristotelis
发表日期：2022
文献求助 收藏